Hasan Suha Ergin is a Carlsbad, California based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Hasan Suha Ergin is G33378 for Ophthalmology in California. Hasan Suha Ergin is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Hasan Suha Ergin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
3925 Skyline Rd, Carlsbad, California, 92008-2746
Phone:
760-803-8090
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1437652278
NPI Enumeration Date:
16 Mar, 2018
NPI Last Update On:
17 Mar, 2018
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Hasan Suha Ergin are as mentioned below.
License Number
Specialization
State
Status
G33378
Ophthalmology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3925 Skyline Rd, Carlsbad, California
Zip:
92008-2746
Phone Number:
760-803-8090
Fax Number:
--
Patients can reach Hasan Suha Ergin at 3925 Skyline Rd, Carlsbad, California or can call to book an appointment on 760-803-8090. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.